Overview

Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder

Status:
Completed
Trial end date:
2018-02-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of treatment with vortioxetine on participant goal achievement after a change in antidepressant medication for the treatment of major depressive disorder (MDD).
Phase:
Phase 4
Details
Lead Sponsor:
Takeda
Treatments:
Vortioxetine